Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1927-1931

  Vaeteewoottacharn, Kulthida ^a   Jearanaikoon, Patcharee ^b   Ponglikitmongkol, Mathurose ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Co mutation; E6; E7; HPV16

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; NUCLEOTIDE; VIRUS DNA; VIRUS VACCINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CARCINOGENICITY; CORRELATION ANALYSIS; DRUG RESEARCH; E6 GENE; E7 GENE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GEOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS GENE; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS; THAILAND; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0037862058     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802, 1995.
2. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX and Wheeler CM: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-72, 1997.
3. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, Parkin DM and Ferlay J: Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 4: 475-83, 1995.
4. Ekalaksananan T, Pientong C, Kotimanusvanij D, Kongyingyoes B, Sriamporn S and Jintakanon D: The relationship of human papillomavirus (HPV) detection to pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand. J Obstet Gynaecol Res 27: 117-24, 2001.
5. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ and Walboomers JM: Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90: 50-7, 1998.
6. Thomas DB, Ray RM, Koetsawang A, Kiviat N, Kuypers J, Qin Q, Ashley RL and Koetsawang S: Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 153: 723-31, 2001.
7. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-4, 1985.
8. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE and Gissmann L: Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1: 251-6, 1987.
9. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-21, 1989.
10. Zehbe I, Wilander E, Delius H and Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58: 829-33, 1998.
11. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G and Madrigal-de la Campa A: Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93: 1325-30, 2001.
12. Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T and Taketani Y: Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156: 159-65, 2000.
13. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C and Singer A: Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69: 364-8, 1996.
14. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK and Kiviat NB: Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89: 796-802, 1997.
15. Hu X, Pang T, Guo Z, Ponten J, Nister M and Bernard Afink G: Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J Pathol 195: 307-11, 2001.
16. van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ and Walboomers JM: Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81: 317-25, 2000.
17. Blin N and Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303-8, 1976.
18. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H and Iwamoto A: Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82: 524-31, 1991.
19. Seedorf K, Krammer G, Durst M, Suhai S and Rowekamp WG: Human papillomavirus type 16 DNA sequence. Virology 145: 181-5, 1985.
20. Choo KB, Wang TS and Huang CJ: Analysis of relative binding affinity of E7-pRB of human papillomavirus 16 clinical variants using the yeast two-hybrid system. J Med Virol 61: 298-302, 2000.
21. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R and Icenogle J: Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70: 6987-93, 1996.
22. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH and Lee HP: Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 66: 275-81, 1997.
23. Eschle D, Durst M, ter Meulen J, Luande J, Eberhardt HC, Pawlita M and Gissmann L: Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 73: 1829-32, 1992.
24. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E and Tommasino M: Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94: 711-6, 2001.
25. Fujinaga Y, Okazawa K, Nishikawa A, Yamakawa Y, Fukushima M, Kato I and Fujinaga K: Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9: 85-92, 1994.
26. Meissner JD: Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80: 1725-33, 1999.
27. Stauss HJ, Davies H, Sadovnikova E, Chain B, Horowitz N and Sinclair C: Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proc Natl Acad Sci USA. 89: 7871-5, 1992.
28. Sang BC and Barbosa MS: Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Proc Natl Acad Sci USA 89: 8063-7, 1992.
29. Edmonds C and Vousden KH: A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 63: 2650-6, 1989.
30. Massimi P, Pim D, Storey A and Banks L: HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12: 2325-30, 1996.